Liver Cancer

Medicine & Life Sciences

1. alpha-Fetoproteins 5%
2. Biomarkers 10%
3. Cholangiocarcinoma 13%
4. Chronic Disease 6%
5. Chronic Hepatitis C 5%
6. Clinical Trials 5%
7. Collagen 6%
8. Elasticity Imaging Techniques 6%
9. Extracellular Matrix 5%
10. Fatty Liver 10%
11. Fibrosis 42%
12. gadolinium ethoxybenzyl DTPA 6%
13. Genes 8%
14. Hepacivirus 19%
15. Hepatic Stellate Cells 41%
16. Hepatitis C 14%
17. Hepatocellular Carcinoma 100%
18. Hepatocytes 8%
19. Kruppel-Like Factor 6 7%
20. Liver 62%
21. Liver Cirrhosis 24%
22. Liver Diseases 19%
23. Liver Neoplasms 16%
24. Liver Transplantation 38%
25. Living Donors 8%
26. Magnetic Resonance Imaging 6%
27. Mutation 6%
28. Neoplasm Metastasis 5%
29. Neoplasms 25%
30. Non-alcoholic Fatty Liver Disease 13%
31. Proteins 5%
32. ramucirumab 5%
33. Recurrence 9%
34. Response Evaluation Criteria in Solid Tumors 5%
35. Sorafenib 15%
36. Survival 17%
37. Therapeutics 14%
38. Tissue Donors 5%
39. Transforming Growth Factors 5%
40. Transplantation 6%
41. Transplants 8%
42. Wounds and Injuries 9%